Oracle (ORCL) IM Urges Thoratec (THOR) to Retain Investment Bank
Tweet
Share
E-mailGet Alerts ORCL Hot Sheet
Price: $146.47 +3.10%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.7%
Revenue Growth %: +28.1%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.7%
Revenue Growth %: +28.1%
Join SI Premium – FREE
Oracle (Nasdaq: ORCL) Investment Management, Inc., which together with its affiliates is a longtime and significant shareholder of Thoratec Corporation (Nasdaq: THOR), has sent a letter to Thoratec's Board of Directors stating Oracle's belief that Thoratec will be unable to maximize shareholder value as an independent public company and urging the Board to retain an investment bank to conduct an auction to find a suitable acquirer for Thoratec.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Real and RE/MAX Holdings receive court approval for merger
- Hinge Health signs $86M office lease in San Francisco
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
